A detailed history of Aia Group LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Aia Group LTD holds 16,291 shares of MRNA stock, worth $658,645. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,291
Previous 14,526 12.15%
Holding current value
$658,645
Previous $1.72 Million 36.89%
% of portfolio
0.03%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$63.64 - $125.14 $112,324 - $220,872
1,765 Added 12.15%
16,291 $1.09 Million
Q2 2024

Jul 31, 2024

BUY
$101.21 - $166.61 $154,446 - $254,246
1,526 Added 11.74%
14,526 $1.72 Million
Q1 2024

May 06, 2024

SELL
$85.37 - $115.44 $107,907 - $145,916
-1,264 Reduced 8.86%
13,000 $1.39 Million
Q4 2023

Jan 31, 2024

BUY
$69.51 - $104.43 $25,371 - $38,116
365 Added 2.63%
14,264 $1.42 Million
Q3 2023

Nov 01, 2023

BUY
$96.41 - $126.61 $227,624 - $298,926
2,361 Added 20.46%
13,899 $1.44 Million
Q2 2023

Jul 28, 2023

BUY
$118.5 - $160.53 $304,071 - $411,919
2,566 Added 28.6%
11,538 $1.4 Million
Q1 2023

Apr 28, 2023

BUY
$135.66 - $197.02 $648,454 - $941,755
4,780 Added 114.03%
8,972 $1.38 Million
Q4 2022

Jan 31, 2023

SELL
$118.38 - $210.04 $358,809 - $636,631
-3,031 Reduced 41.96%
4,192 $752,000
Q3 2022

Nov 04, 2022

SELL
$118.07 - $194.18 $149,712 - $246,220
-1,268 Reduced 14.93%
7,223 $854,000
Q2 2022

Aug 11, 2022

SELL
$117.13 - $176.59 $848,489 - $1.28 Million
-7,244 Reduced 46.04%
8,491 $1.21 Million
Q1 2022

May 06, 2022

BUY
$126.46 - $235.05 $1.09 Million - $2.03 Million
8,620 Added 121.15%
15,735 $2.71 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $153,557 - $250,586
680 Added 10.57%
7,115 $1.81 Million
Q3 2021

Nov 05, 2021

BUY
$221.9 - $484.47 $884,049 - $1.93 Million
3,984 Added 162.55%
6,435 $2.48 Million
Q2 2021

Aug 03, 2021

BUY
$129.91 - $234.98 $318,409 - $575,935
2,451 New
2,451 $769,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Aia Group LTD Portfolio

Follow Aia Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aia Group LTD with notifications on news.